We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Priaxon Appoints Dr Constance Hoefer as Chief Development Officer

News   Jan 09, 2014

 
Priaxon Appoints Dr Constance Hoefer as Chief Development Officer
 
 
 

RELATED ARTICLES

Experimental Respiratory Virus Vaccine Prompts Antibody Surge

News

A novel experimental vaccine against respiratory syncytial virus (RSV), a leading cause of severe respiratory illness in the very young and the old, has shown early promise in a Phase 1 clinical trial.

READ MORE

Predatory Journals Could Damage the Credibility of Scientific Publishing

News

'Predatory journals' pose a danger that could undermine the quality, integrity, and reliability of published scientific research, a new joint statement from three leading organizations, professional in medical writing and publication planning, has warned.

READ MORE

Artificial Protein Ushers In New Era of “Smart” Cell Therapies

News

Researchers have created “smart” cells that behave like tiny autonomous robots which, in the future, may be used to detect damage and disease, and deliver help at just the right time and in just the right amount.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE